Study:
Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)
Rationale:
n/a
Purpose:
The EchoCRT trial evaluates the effects of Cardiac Resynchronization Therapy (CRT) on
mortality and morbidity of subjects with heart failure due to left ventricular systolic
dysfunction, already receiving optimized HF medication, with a narrow QRS width (< 130 ms)
and echocardiographic evidence of ventricular dyssynchrony.
Study Status: Terminated
Recruiting:
n/a
| Condition |
Intervention |
Phase |
Heart Failure
Ventricular Dyssynchrony |
Device: Implantable Cardioverter Defibrillator with Cardiac Resynchronization Therapy (BIOTRONIK Lumax HF-T CRT-D) |
Phase 2/Phase 3 |
Verified by
Biotronik, Inc.
April, 2013
Sponsored by: Biotronik, Inc.
Information provided by: Biotronik, Inc.
ClinicalTrials.gov identifier: NCT00683696
Study Type: Interventional
Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Cleveland Clinic
Cleveland, Ohio 44145
United States
Frank Ruschitzka, MD., Study Chair
Johannes Holzmeister, MD., Study Chair
William Abraham, MD., Principal Investigator
Jagmeet Singh, MD., Principal Investigator